1
UC Answers: How are UC researchers tackling COVID-19?
July 29, 2020
Brett Kissela, MD, discusses ways UC researchers are making an impact during the COVID-19 pandemic.
1812 Results
2
Sit up, raise the screen, pad the chair
July 28, 2020
Kermit Davis, PhD, conducted an ergonomic assessment of employees at the University of Cincinnati sending out an email survey to 4,500 faculty and staff after the coronavirus pandemic prompted the university to join many other employers across the nation in sending workers home to continue operations. The survey had 843 people complete it. As part of the study, 41 employees sent Davis photos of workers at home workstations for ergonomic review. This subset showed some trends and offered a glimpse into what many who work from home are encountering. The survey’s findings were recently published in the scholarly journal Ergonomics in Design.
3
COVID-19 may attack patients’ central nervous system
July 14, 2020
Ahmad Sedaghat, MD, PhD, conducted a prospective, cross-sectional telephone questionnaire study which examined characteristics and symptoms of 114 patients who were diagnosed with COVID-19 over a six-week period at Kantonsspital Aarau in Aarau, Switzerland. Depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign the virus affects the central nervous system, according to Sedaghat, a University of Cincinnati College of Medicine researcher.
4
UC COVID-19 research examines the safety and efficacy of immune regulating drug
July 15, 2020
Researchers at UC are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial. The research trial, called Sirolimus Treatment in Hospitalized Patients with COVID-19 Pneumonia (SCOPE), will examine the Food and Drug Administration-approved medication that is most commonly used to prevent organ rejection in patients with kidney transplants. It is also FDA-approved for the treatment of a rare lung disease, LAM.
5
Healthline: Lysol disinfectant approved for use against COVID-19: Here’s what else can work
July 14, 2020
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was featured as a source in a story on Healthline on the FDA approval of using the disinfectant Lysol against COVID-19.
6
Popular Science: Pandemic water activities, ranked from risky to riskiest
July 6, 2020
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases talked to Popular Science Magazine about what summer activities are riskier than others during the COVID-19 pandemic.
7
WVXU: How walking backward might help stroke survivors
July 1, 2020
WVXU highlights research by Oluwole Awosika, MD, who is examining how walking backward on a treadmill might help stroke survivors learn to walk again.
8
Texas Public Radio: Is COVID-19 A Vascular Disease?
July 2, 2020
COVID-19 appears to be a multi-system inflammatory disease. It may begin in the lungs but is escaping to other parts of the body. Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, shares his knowledge about COVID-19 and the cardiovascular system with Texas Public Radio.
9
Understanding pancreatic cancer, one gene at a time
July 6, 2020
Krushna Patra, PhD, received one of 10 Career Development Awards from PanCAN to continue his work studying genetic mutations that cause pancreatic cancer.
10
College of Nursing, CPS look to sustain health professions pipeline program
July 6, 2020
The grant-funded HEALTH Pathways program, a partnership between Cincinnati Public Schools and UC College of Nursing, succeeded in helping more high school students enter college and pursue health care careers.